ERVW-1 and infection: In this report, we show that priming with DNA encoding a trimeric HIV V1V2 immunogen is more efficient than vaccination with DNA expressing the complete Env molecule in focusing the Ab responses on the V2 epitopes associated with reduced risk of infection, as reported in the RV144 trial.